Business Description

The Native Antigen Company is a developer and manufacturer of infectious disease reagents – native and recombinant antigens, antibodies and immunoassays for viruses and bacteria.

Rationale for Investment

Opportunity to be a leading developer, manufacturer and supplier of reagent products as well as custom and contract services to diagnostics and biopharmaceuticals customers.

www.thenativeantigencompany.com

Business Description

PsiOxus Therapeutics is a developer of novel therapeutics for solid tumours through its proprietary targeted oncolytic virus and tumour-specific immuno-gene therapy platform (T-SIGn).

Rationale for Investment

To be a world-leading cancer gene therapy company, developing an internal programme and entering into commercial partnerships to advance a oncolytic virus pipeline.

www.psioxus.com

Business Description

OXGENE™ has leading expertise in gene therapy, gene editing and antibody discovery. Its expert teams excel in mammalian cell engineering solutions, coupled with bioinformatics and automation to build robust and efficient biotechnology solutions. OXGENE™ is a trading name of Oxford Genetics LTD

Rationale for Investment

Opportunity to accelerate the discovery, development and manufacture of new cell and gene therapies. OXGENE’s technologies and solutions aim to reduce the overall cost of goods involved in the manufacture of these new treatment types and so increase patient accessibility.

 

 

 

 

Business Description

Medherant is a developer of transdermal drug-in-adhesive patches using a novel adhesive exclusively licensed from Bostik, targeting central nervous system and pain indications.

Rationale for Investment

Building a leader in transdermal drug formulation and delivery, developing and out-licensing its own products as well as products of external partners seeking transdermal solutions.

www.medherant.co.uk

Business Description

Eyoto designs and develops optometry diagnostics equipment that are digital and portable. Its first product is the eMap, an analyser for evidence-based lens production and dispensing.

Rationale for Investment

Building on eMap, the company has the opportunity to be a leader in optometry diagnostics equipment and software solutions to meet the needs of the global eye care market.

www.eyoto.com

Business Description

Warwick Acoustics develops, manufactures and markets a new class of electrostatic audio systems that deliver superior design and listening experiences for headphone and automotive uses.

Rationale for Investment

Building on award-winning headphones for audiophiles, to become a leading developer of best-in-class audio systems for automotive and interior component OEMs and suppliers.

www.warwickacoustics.com

Business Description

LM Technologies designs, develops and manufactures wireless modules and adapters, enabling the Internet of Things (IoT) by providing technology solutions across a number of industries.

Rationale for Investment

To be a leading technology enabler in Internet of Things (IoT) applications by designing and developing data connectivity products with Bluetooth®, WiFi™ and other mobile technologies

www.lm-technologies.com

Business Description

Impression Technologies has developed a process technology for manufacturing light-weighted components using high-strength aluminium, known as Hot Form Quench (HFQ®).

Rationale for Investment

Commercialising HFQ®, exclusively licensed from Imperial College London, through its own facility and a licensing model, with adoption by high-end automotive OEMs and suppliers.

www.impression-technologies.com

Intechnica

A digital performance company, with accelerated revenue, winning clients winning new clients for its bot management product, Netacea. Its virtual waiting room product for e commerce businesses has also gained traction winning deals with major national retailers.

Netacea was identified by Forrester as “leading the pack” in the sector.

Voxpopme

The business has demonstrated rapid growth in both the US and Europe, with recurring revenues having increased over 450% since initial investment. Customers include many of the world’s best-known consumer brands – Kimberly-Clark, Unilever, Mars, Mondelez, and AB InBev. With investment from both Mercia’s balance sheet and the Northern VCTs in September 2019, Voxpopme illustrates the synergies between the funds even prior to the acquisition in December 2019.

Clear Review

Clear Review is a SaaS business providing HR management tools. HR technology remains an exciting sector indicative of the overall momentum of Clear Review, passing its key revenue milestones in annual recurring revenue in December 2019,

Mercia first invested in Clear Review in 2018 through its managed funds and provided an initial £0.5million direct equity investment alongside co-investor Albion VCT in June 2019.

Business Description

Voxpopme is a developer and provider of a video analytics platform, enabling brands to capture, analyse and share video content for market research and customer experience insight

Rationale for Investment

Growing sales and developing new data analytics products, building a leading video data analytics business in market research and customer experience in the UK and internationally

www.site.voxpopme.com